My Cart

IFN-alpha/beta R1

IFN-alpha/beta R1 Overview

English NameInterferon-alpha/beta receptor alpha chainApproved Drugs5
Drugs in Clinical Trials0Target SynonymIFNBR,IFN-Alpha-REC,Beta-Type Antiviral Protein,IFNAR,Cytokine Receptor Class-II Member 1,Interferon Receptor 1,IFNAR1,Interferon Alpha/Beta Receptor 1,Interferon Alpha And Beta Receptor Subunit 1,Type I Interferon Receptor 1,Interferon (Alpha, Beta And Omega) Receptor 1,Alpha-Type Antiviral Protein,IFN-Alpha/Beta Receptor 1,AVP,Interferon-Beta Receptor 1,IFRC,IFN-R-1,CRF2-1,Cytokine Receptor Family 2 Member 1,Interferon-Alpha/Beta Receptor Alpha Chain
Highest Development StageApproved
English NameInterferon-alpha/beta receptor alpha chain
Target SynonymIFNBR,IFN-Alpha-REC,Beta-Type Antiviral Protein,IFNAR,Cytokine Receptor Class-II Member 1,Interferon Receptor 1,IFNAR1,Interferon Alpha/Beta Receptor 1,Interferon Alpha And Beta Receptor Subunit 1,Type I Interferon Receptor 1,Interferon (Alpha, Beta And Omega) Receptor 1,Alpha-Type Antiviral Protein,IFN-Alpha/Beta Receptor 1,AVP,Interferon-Beta Receptor 1,IFRC,IFN-R-1,CRF2-1,Cytokine Receptor Family 2 Member 1,Interferon-Alpha/Beta Receptor Alpha Chain
Approved Drugs5
Drugs in Clinical Trials0
Highest Development StageApproved

IFN-alpha/beta R1 Background

Interferon alpha/beta receptor 1 ( IFNAR1) is also known as Cytokine receptor class-II member 1, Cytokine receptor family 2 member 1 (CRF2-1), Type I interferon receptor 1, IFNAR, which belongs to the type II cytokine receptor family. IFNAR1 /IFNAR contains four fibronectin type-III domains. IFNAR1 associates with IFNAR2 to form the type I interferon receptor. IFNAR1 is receptor for interferons alpha and beta. IFNAR1 can transduce IFNB signals without the help of IFNAR2, and not activating the Jak-STAT pathway.

IFN-alpha/beta R1 Synonyms

IFNAR1,IFNAR,CRF2-1,IFN-R-1,IFNAR-1

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Interferon beta (Toray/Daiichi Sankyo)DL-8234ApprovedToray Industries IncFeronJapanMedulloblastoma; Melanoma; Hepatitis C; Astrocytoma; Glioblastoma; Hepatitis Bnull1985-04-01Astrocytoma; Glioblastoma; Hepatitis B; Hepatitis C; Medulloblastoma; Melanoma
Details
Recombinant human interferon alfa-2b (Harbin Pharmaceutical Group Bioengineering)ApprovedHarbin Pharmaceutical Group Holding Co Ltd里亚美, 利分能Mainland ChinaHepatitis, Viral, Human; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic; Lymphoma, Non-Hodgkin; Multiple Myeloma; Condylomata Acuminata; Varicella Zoster Virus InfectionHarbin Pharmaceutical Group Pharmaceutical Co Ltd1996-01-01Condylomata Acuminata; Hepatitis, Viral, Human; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic; Lymphoma, Non-Hodgkin; Multiple Myeloma; Varicella Zoster Virus Infection
Details
Recombinant human interferon α2b biosimilar (Harbin High-Tech White Swan Pharmaceutical)ApprovedHarbin High-Tech Group Baitian'Er Pharmaceutical Co LtdFu Li ShengCondylomata Acuminata; Hepatitis; Herpes Zoster; Leukemia, Hairy Cell; Leukemia, Myeloid, Chronic-Phase; Lymphoma, Non-Hodgkin; Multiple Myeloma
Details
AnifrolumabMEDI-546; MDX-1333ApprovedMedarex Inc, Medimmune LlcSAPHNELOUnited StatesLupus Erythematosus, SystemicAstrazeneca Ab2021-07-30Atherosclerosis; Autoimmune Diseases; Cardiovascular Diseases; Dermatomyositis; Hidradenitis; Hidradenitis Suppurativa; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Lupus Nephritis; Myositis; Polymyositis; Scleroderma, Systemic; Sjogren's Syndrome; Vitiligo
Details
Recombinant human interferon α2b biosimilar (Zhejiang Hansheng)ApprovedZhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma莱福隆Mainland ChinaVirus Diseases; NeoplasmsZhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma1999-01-01Neoplasms; Virus Diseases
Details
  • Overview
  • Product List
  • Marketed Drug Information